EMBC
$8.91
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally.
Intraday
Recent News
We Think Embecta's (NASDAQ:EMBC) Solid Earnings Are Understated
Despite posting healthy earnings, Embecta Corp.'s ( NASDAQ:EMBC ) stock has been quite weak. Our analysis suggests that...
Embecta (NASDAQ:EMBC) Is Paying Out A Dividend Of $0.15
The board of Embecta Corp. ( NASDAQ:EMBC ) has announced that it will pay a dividend of $0.15 per share on the 17th of...
3 Healthcare Stocks Paying the Highest Dividends of 2026
Which of the highest-yielding healthcare stocks are value traps or golden opportunities?
Embecta Q1 Earnings Call Highlights
Embecta (NASDAQ:EMBC) said it is transitioning from a “stand-up” phase of independence to a “seed growth” phase as management works to stabilize its core insulin delivery franchise, expand the portfolio, and build financial flexibility. On the company’s fiscal first-quarter 2026 earnings call, execu
Embecta Corp (EMBC) Q1 2026 Earnings Call Highlights: Strategic Progress Amidst Market Challenges
Embecta Corp (EMBC) showcases strong international growth and strategic advancements in GLP-1 collaborations, despite facing pricing pressures in the US market.